REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q3 2021. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,290 | -52.2% | 30,212 | -23.2% | 0.00% | -75.0% |
| Q3 2022 | $1,040,000 | +170.1% | 39,362 | +239.3% | 0.00% | +300.0% |
| Q1 2022 | $385,000 | -93.9% | 11,600 | -92.3% | 0.00% | -92.9% |
| Q3 2021 | $6,330,000 | +775.5% | 150,994 | +711.8% | 0.01% | +600.0% |
| Q2 2021 | $723,000 | -82.1% | 18,600 | -84.3% | 0.00% | -81.8% |
| Q1 2021 | $4,046,000 | +1002.5% | 118,606 | +1364.3% | 0.01% | +1000.0% |
| Q4 2020 | $367,000 | +49.2% | 8,100 | -9.4% | 0.00% | 0.0% |
| Q3 2020 | $246,000 | -84.7% | 8,940 | -79.5% | 0.00% | -87.5% |
| Q2 2020 | $1,609,000 | -10.8% | 43,691 | +38.8% | 0.01% | +33.3% |
| Q1 2019 | $1,804,000 | -64.6% | 31,473 | -74.1% | 0.01% | -70.0% |
| Q4 2018 | $5,094,000 | -47.5% | 121,420 | -5.5% | 0.02% | -23.1% |
| Q3 2018 | $9,703,000 | +427.3% | 128,514 | +108.5% | 0.03% | +333.3% |
| Q1 2018 | $1,840,000 | -56.8% | 61,637 | -51.8% | 0.01% | -57.1% |
| Q4 2017 | $4,255,000 | +111.1% | 127,967 | +109.1% | 0.01% | +100.0% |
| Q3 2017 | $2,016,000 | – | 61,192 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |